Jie YAN,Wenjie XU,Jianqiong ZHI,Song LI,Yang WANG,Yanxin ZHENG
申请号：
US16071377
公开号：
US20200061025A1
申请日:
2017.01.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
